Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease

被引:21
作者
Abe, Yasuhisa
Matsubara, Daisuke
Gatanaga, Hiroyuki
Oka, Shinichi
Kimura, Satoshi
Sasao, Yuki
Saitoh, Kiyoshi
Fujii, Takeshi
Sato, Yuko
Sata, Tetsutaro
Katano, Harutaka
机构
[1] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan
[2] Int Med Ctr Japan, Dept Pathol, Tokyo, Japan
[3] Int Med Ctr Japan, AIDS Clin Ctr, Tokyo, Japan
关键词
Kaposi's sarcoma-associated herpesvirus; Kaposi's sarcoma; multicentric Castleman's disease; open reading frame 59; viral interleukin-6;
D O I
10.1111/j.1440-1827.2006.02017.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The expression of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-encoded proteins is herein demonstrated in Kaposi's sarcoma (KS) and multicentric Castleman's disease (MCD) in a single lymph node derived from a patient with acquired immunodeficiency syndrome. Immunohistochemistry revealed that both lytic and latent KSHV proteins were expressed in cells of the MCD lesion. KSHV-encoded viral interleukin-6 was also detected in follicular dendritic cells of the germinal center. Cytoplasmic localization of open reading frame 59 protein and latency-associated nuclear antigen suggested KSHV activation in the MCD lesion. Moreover, a high copy number of KSHV was detected in the blood. Clinically, pegylated-liposomal doxorubicin induced regression of not only KS, but also lymphadenopathy of the MCD lesion with a decrease in KSHV load and human interleukin-6 in the blood. To the best of the authors' knowledge this is the first case demonstrating differential expression of virus proteins in two KSHV-associated diseases, KS and MCD, in the same section. The case confirms lytic KSHV infection in MCD, and suggests that clinical symptoms of MCD might be closely linked with KSHV activation.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 53 条
[1]   Kaposi's sarcoma [J].
Antman, K ;
Chang, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) :1027-1038
[2]   Serum viral interleukin-6 in AIDS-related multicentric Castleman disease [J].
Aoki, Y ;
Tosato, G ;
Fonville, TW ;
Pittaluga, S .
BLOOD, 2001, 97 (08) :2526-2527
[3]   Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease [J].
Bacon, CM ;
Miller, RF ;
Noursadeghi, M ;
McNamara, C ;
Du, MQ ;
Dogan, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (05) :585-591
[4]   ALLEVIATION OF SYSTEMIC MANIFESTATIONS OF CASTLEMANS DISEASE BY MONOCLONAL ANTI-INTERLEUKIN-6 ANTIBODY [J].
BECK, JT ;
HSU, SM ;
WIJDENES, J ;
BATAILLE, R ;
KLEIN, B ;
VESOLE, D ;
HAYDEN, K ;
JAGANNATH, S ;
BARLOGIE, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :602-605
[5]  
Bollen JM, 2003, BMC Blood Disord, V3, P3, DOI 10.1186/1471-2326-3-3
[6]   The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care [J].
Casper, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (01) :3-17
[7]   Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment [J].
Casper, C ;
Nichols, WG ;
Huang, ML ;
Corey, L ;
Wald, A .
BLOOD, 2004, 103 (05) :1632-1634
[8]   Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody [J].
Chan, SR ;
Bloomer, C ;
Chandran, B .
VIROLOGY, 1998, 240 (01) :118-126
[9]   Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains [J].
Chan, SR ;
Chandran, B .
JOURNAL OF VIROLOGY, 2000, 74 (23) :10920-10929
[10]   Viral IL-6-induced cell proliferation and immune evasion of interferon activity [J].
Chatterjee, M ;
Osborne, J ;
Bestetti, G ;
Chang, Y ;
Moore, PS .
SCIENCE, 2002, 298 (5597) :1432-1435